Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: The company could have supported us @ .50 volume Why not?

The company could have supported us @ .50 volume Why not?

posted on Apr 14, 2008 06:44AM

Something is up I hope it's a good thing for us longs. At this point a buyout looks possible? Whatever happens I've lost a chunk unless things change. We as share holders would have to approve a buyout or takeover am I correct?

Bluewing

 

Share
New Message
Please login to post a reply